BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1317291)

  • 1. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths.
    Behrendtsen O; Alexander CM; Werb Z
    Development; 1992 Feb; 114(2):447-56. PubMed ID: 1317291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.
    Chen L; Nakai M; Belton RJ; Nowak RA
    Reproduction; 2007 Feb; 133(2):405-14. PubMed ID: 17307908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor.
    Harvey MB; Leco KJ; Arcellana-Panlilio MY; Zhang X; Edwards DR; Schultz GA
    Development; 1995 Apr; 121(4):1005-14. PubMed ID: 7743917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
    Sharma RK
    In Vivo; 1998; 12(2):209-17. PubMed ID: 9627804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of matrix metalloproteinases in development.
    Werb Z; Alexander CM; Adler RR
    Matrix Suppl; 1992; 1():337-43. PubMed ID: 1480058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
    Alexander JP; Bradley JM; Gabourel JD; Acott TS
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture.
    Talhouk RS; Chin JR; Unemori EN; Werb Z; Bissell MJ
    Development; 1991 Jun; 112(2):439-49. PubMed ID: 1794314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation.
    Alexander CM; Hansell EJ; Behrendtsen O; Flannery ML; Kishnani NS; Hawkes SP; Werb Z
    Development; 1996 Jun; 122(6):1723-36. PubMed ID: 8674412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development.
    Brenner CA; Adler RR; Rappolee DA; Pedersen RA; Werb Z
    Genes Dev; 1989 Jun; 3(6):848-59. PubMed ID: 2744464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase expression during mouse peri-implantation development.
    Sharkey ME; Adler RR; Nieder GL; Brenner CA
    Am J Reprod Immunol; 1996 Aug; 36(2):72-80. PubMed ID: 8862249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
    Reynolds JJ
    Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos.
    Whiteside EJ; Jackson MM; Herington AC; Edwards DR; Harvey MB
    Biol Reprod; 2001 May; 64(5):1331-7. PubMed ID: 11319136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution.
    Talhouk RS; Bissell MJ; Werb Z
    J Cell Biol; 1992 Sep; 118(5):1271-82. PubMed ID: 1512297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells.
    Unemori EN; Bouhana KS; Werb Z
    J Biol Chem; 1990 Jan; 265(1):445-51. PubMed ID: 2152926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
    Alexander JP; Samples JR; Van Buskirk EM; Acott TS
    Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.
    Murphy G; Ward R; Hembry RM; Reynolds JJ; Kühn K; Tryggvason K
    Biochem J; 1989 Mar; 258(2):463-72. PubMed ID: 2539808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
    Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
    J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and implications of tissue inhibitor of metalloproteinases-4 in mouse embryo.
    Zhang J; Zhao YG; Cao YJ; Sang QX; Duan EK
    Mol Hum Reprod; 2003 Mar; 9(3):143-9. PubMed ID: 12606590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.
    Das SK; Yano S; Wang J; Edwards DR; Nagase H; Dey SK
    Dev Genet; 1997; 21(1):44-54. PubMed ID: 9291579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.